MARKET

LGND

LGND

Ligand Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

86.54
-2.00
-2.26%
After Hours: 86.54 0 0.00% 17:37 01/27 EST
OPEN
87.08
PREV CLOSE
88.54
HIGH
89.34
LOW
85.70
VOLUME
415.02K
TURNOVER
--
52 WEEK HIGH
130.50
52 WEEK LOW
84.45
MARKET CAP
1.65B
P/E (TTM)
3.112
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of LGND and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

LGND News

  • Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics
  • Business Wire.01/13 21:02
  • Top Biotech Stocks for Q1 2020
  • Investopedia.01/09 19:50
  • Ligand to Report 2019 Fourth Quarter and Full Year Financial Results on February 6th
  • Business Wire.01/09 19:47
  • Does Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Have A High Beta?
  • Simply Wall St..01/08 16:04

More

Industry

Biotechnology & Medical Research
-0.88%
Pharmaceuticals & Medical Research
-0.51%

Hot Stocks

Name
Price
%Change

About LGND

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company that focuses on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company is involved in the development and licensing of biopharmaceutical assets. The Company employs research technologies, such as nuclear receptor assays, high throughput computer screening, formulation science, liver targeted pro-drug technologies and antibody discovery technologies to assist companies in their work toward obtaining prescription drug approvals. As of December 31, 2016, it had partnerships and license agreements with over 85 pharmaceutical and biotechnology companies, and over 140 various programs under license with it were in various stages of commercialization and development. It has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others.
More

Webull offers Ligand Pharmaceuticals Inc. (LGND) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.